Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia

2 Views
administrator
administrator
08/04/23

In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next